CHRN Market Analysis

Fundamentals

Updated daily after market close
P/E ratio
EPS (TTM)$-0.510.0% YoY
Profit margin-86.2%TECHNOLOGY
Market cap$3.20BMid cap

Valuation

Forward P/E
PEG ratio
P/B
32.48
P/S (TTM)
37.91
EV/EBITDA
132.97

Profitability & growth

ROE (TTM)
0.0%
Operating margin
-39.4%
Revenue growth YoY
0.0%
Dividend yield
Beta
0.99
Last earnings
Apr 28, 2026 · Reported $-2.04
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

About ChronoScale Corporation

Company profile

ChronoScale Corporation (Ticker: CHRN) is a cutting-edge biotechnology company dedicated to transforming healthcare by developing and commercializing innovative therapeutics that address unmet medical needs. The firm boasts a robust pipeline supported by strategic collaborations and is committed to leveraging advanced technologies to enhance patient care outcomes. Through its unwavering focus on scientific excellence and a dynamic approach to the evolving healthcare landscape, CHRN is strategically positioned to emerge as a prominent leader in the biotechnology sector, poised to capitalize on…

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
3811 TURTLE CREEK BLVD., DALLAS, TX
Fiscal year end
May
Latest quarter
May 31, 2025
Market cap$3.20B
Shares outstanding$145.2M
52W high$30.00
52W low$2.91

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer